NovoCure (NVCR) Return on Capital Employed Growth (5y) (2020 - 2026)
NovoCure (NVCR) Return on Capital Employed Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,857.00 |
| Mar 31, 2026 | -3,524.00 |
| Dec 31, 2025 | -2,274.00 |
| Sep 30, 2025 | -3,830.00 |
| Jun 30, 2025 | -3,641.00 |
| Mar 31, 2025 | -3,372.00 |
| Dec 31, 2024 | -3,565.00 |
| Sep 30, 2024 | -3,014.00 |
| Jun 30, 2024 | -1,257.00 |
| Mar 31, 2024 | -1,245.00 |
| Dec 31, 2023 | -1,128.00 |
| Sep 30, 2023 | -1,136.00 |
| Jun 30, 2023 | -719.00 |
| Mar 31, 2023 | 172.00 |
| Dec 31, 2022 | 967.00 |
| Sep 30, 2022 | 1,729.00 |
| Jun 30, 2022 | 2,798.00 |
| Mar 31, 2022 | 3,564.00 |
| Dec 31, 2021 | 4,169.00 |
| Sep 30, 2021 | 5,221.00 |